TrueLab Biopharmaceutical
PrivateLast Round
VC Round
Jun 22, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TrueLab Biopharmaceutical is an immunology-driven biopharmaceutical company that discovers and develops differentiated therapies for immune-mediated inflammatory diseases using its proprietary TrueForge™ AI-powered R&D platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TrueLab Biopharmaceutical Comparables
Compare TrueLab Biopharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Earendil Labs | 82% | |
| Shanghai Novamab Biopharmaceuticals | 81% | |
| Roche Holding | 80% |
TrueLab Biopharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 22, 2026 |
TrueLab Biopharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tencent Exploration | VC Round |
| Loyal Valley Capital | VC Round |
| Legend Capital | VC Round |
| Huagai Capital | VC Round |
| Bayland Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
$53M raised from Loyal Valley Capital and Tencent Exploration.
TrueLab Biopharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TrueLab Biopharmaceutical's valuation, stock price, and market status.
Is TrueLab Biopharmaceutical a public or private company?
TrueLab Biopharmaceutical is a private company.
What is the current stock price of TrueLab Biopharmaceutical?
TrueLab Biopharmaceutical is a private company with no public stock price. No recent secondary market data is available.
How much is TrueLab Biopharmaceutical worth (valuation)?
Valuation information for TrueLab Biopharmaceutical is not publicly available.
Can I buy TrueLab Biopharmaceutical stock?
TrueLab Biopharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TrueLab Biopharmaceutical's last funding round?
TrueLab Biopharmaceutical's most recent funding round was VC Round on June 22, 2026.
Who are the main investors in TrueLab Biopharmaceutical?
Key investors in TrueLab Biopharmaceutical include Tencent Exploration, Loyal Valley Capital, Legend Capital, Huagai Capital.
Will TrueLab Biopharmaceutical IPO soon?
No public IPO plans have been announced for TrueLab Biopharmaceutical.
How can I track TrueLab Biopharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TrueLab Biopharmaceutical's secondary market activity and sign up for updates.